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Abstract: Glucocorticoids (GCs) induce apoptosis and cell cycle arrest in lymphoid cells and are fundamental components of therapeutic
regimens of acute lymphoblastic leukemia (ALL). We previously identified a panel of GC-induced candidate genes in children with
ALL and in other biological systems using whole genome expression profiling. Of those, a novel transcript from the BCL2L11/Bim
locus, named “Bimbam”, was functionally analyzed in the current study. The postulated Bimbam mRNA consists of the 5’ portion
of Bim including the BH3-containing exon 8 and the 3’ portion of Bam, a small 2-exon gene embedded in the BCL2L11/Bim locus.
The expression and GC induction of Bimbam were similar to those of the combined Bim transcripts in ALL cell lines. The functional
analysis with recombinant Bimbam constructs reflected that it induced massive apoptosis on its own and its killing capacity is similar
to that of Bim. The localization data indicated that contrary to Bim, which localized preferentially to mitochondria via its C-terminal
domain, Bimbam localized to mitochondria and also to other intracytoplasmic membranes. Therefore, it may be responsible for some
of the effects previously ascribed to the known Bim transcripts irrespective of the fact that its C-terminus is absolutely different than
Bim’s C-terminus.
Key words: Glucocorticoids, GC regulation, Bimbam, apoptosis, cell cycle arrest

1. Introduction
Acute lymphoblastic leukemia (ALL) mainly affects
children by blocking and obstructing the differentiation of
precursor B and T cells due to aggressive genetic insults
(Pui, 2006). Despite the intensive research in the field of
diagnosis and treatment, some entities of ALL have a much
worse prognosis and leukemia relapse, generally associated
with acquired chemotherapy resistance, still constitutes a
significant clinical problem (Fielding et al., 2007; Harned
et al., 2008). Glucocorticoids (GCs), a subgroup of steroid
hormones, induce cell death (apoptosis) and are primarily
employed in the therapy of hematological malignancies and
pediatric acute lymphoblastic leukemia cells (Cidlowski et
al., 1996; Ashwell et al., 2000; Pui et al., 2004). GC via the
GC receptor, a ligand-activated transcription factor of the
large nuclear receptor family, induces alterations in gene
expression (Laudet and Gronemeyer, 2002). For the last few
years we and others have pursued a systematic microarraybased search for GC-regulated genes in cells sensitive/
resistant to GC-induced apoptosis in experimental systems
* Correspondence: dr.mansha@ue.edu.pk
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and, relatively recently, in children with ALL treated in vivo
or ex vivo (Tonko et al., 2001; Distelhorst, 2002; Hebbar et
al., 2003; Planey et al., 2003; Wang et al., 2003; Schmidt
et al., 2004, 2006). These studies found hundreds of genes
induced by GC, but the fundamental issue of how these
GC-regulated genes contribute to apoptosis induction is
not well understood.
Since the mitochondrial death pathway has been
associated with the execution of GC-mediated cell death,
we and others have largely focused on the key regulatory
molecules of this pathway, i.e. the BCL2 family (Ploner et
al., 2008; Youle et al., 2008). However, the current panel
of BCL2 family members could not completely solve
the enigma of GC-induced cell death. In this regard, we
identified a novel splice variant of Bim by Affymetrix
whole genome expression profiling technique that has
not been reported yet and is named “Bimbam”. The 5’ end
of Bimbam up to exon 8 is similar to Bim, whereas the 3’
end is markedly different from that of Bim and is termed
the Bam C-terminus, being derived from Bam. The Bam
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gene is located within the BCL2L11/Bim locus and gives
rise to a transcript consisting of 2 exons (Claudio et al.,
2002; Mansha et al., 2011, 2012). The predicted length of
the coding region of this transcript is 27 nucleotides longer
than that of the corresponding Bim coding region (Figure
1).
In the present study, we investigate the potential role
of Bimbam in GC-induced apoptosis and examined
the existence of Bimbam mRNA and its GC-regulation
in children with ALL and in multiple cell lines. The
C-terminus of Bimbam is markedly different from that of
Bim and, to understand the putative role of the C-terminus
of Bimbam, different YFP fusion constructs were
generated, transfected into appropriate cells, and analyzed
by laser confocal microscopy. Moreover, the current study
also elucidates the functional role of Bimbam and how its
GC regulation accounts for or is critically associated with
GC-induced cell death.
2. Materials and methods
2.1. Cell lines
All the cell lines used in this study were free of mycoplasma
infection and their authenticity was verified by DNA
fingerprinting as detailed previously (Parson et al., 2005).
The T-ALL cell lines CCRF-CEM-C7H2 (Strasser-Wozak
et al., 1995), CEM-C7H2-2C8 (Loffler et al., 1999), a
CEM-C7H2 derivative with constitutive expression of
the tetracycline-regulated reverse transactivator, rtTA
(Gossen et al., 1995) and MOLT4 (CRL-1582, ATCC,
Rockville, MD, USA) and the precursor B-cell lines
NALM6 (ACC128, DSMZ), RS4;11 (ACC 508, DSMZ),
and AT-1 (Fears et al., 2002) (kindly provided by R Panzer
Grümeier, Vienna) were cultured in RPMI 1640 and HEK
293T (adherent) cells in DMEM supplemented with 10%
FCS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 µg/
mL streptomycin. Cells were cultured at 37 °C in 5% CO2
and saturated humidity and were diluted 1:2 daily or 1:3
every other day to maintain midlog-phase cultures (2.5–6
× 105 cells/mL).
2.2. Lentivirus generation and infection
Packaging cells (1 × 106, 293T human embryonic kidney
cells) were cultured to ~70% confluence and transfected
with 2 µg of expression plasmid (pHR-tetCMV-Bimbam)
along with 1 µg of plasmid coding for vesicular stomatitis
virus VSV-G plus 1 µg pCMV8.91 with 12 µL of
Metafectene. The lentivirus-containing supernatants were
filtered through 0.45-µm syringe filters and centrifuged
onto 5 × 105 C7H2-2C8 (the target cell line having rtTA for
conditional expression of the transgene). The infected cells
were allowed to recover and were subjected to limiting
dilution cloning. After 3 weeks, the Bimbam subclones
were screened with doxycycline, FACS analysis, and
western blot.

2.3. PI staining
Propidium iodide (PI) is a DNA intercalating dye that
was used to stain the cell nuclei before FACS analysis.
Apoptosis was determined by FACS analysis of PI-treated
permeabilized cells (Nicoletti et al., 1991). First, 2–5×105
cells were centrifuged at 1200 rpm, then resuspended
in 600 µL of FACS buffer (50 µg/mL PI, 0.1% sodium
citrate, 0.1% Triton X-100) and kept for a minimum of 6
h at 4 °C protected from light. At least 20,000 events were
analyzed with a FACScan cytometer (Becton Dickinson
Biosciences, San Jose, CA, USA) in combination with
CellQuest Pro software (Becton Dickinson Biosciences)
acquiring forward scatter (FSC)/sideward scatter (SSC),
FL-2 (log), and FL-3 (lin). In FL-2 the percentage of nuclei
with reduced DNA content (sub-G1 peaks) was assessed.
Cell debris was excluded from the analysis.
2.4. Antibodies and immunoblotting
Our immunoblotting method has been published (Gruber
et al., 2009). Briefly, proteins (50 µg) were size-fractioned
by polyacrylamide gel electrophoresis with sodium
dodecyl sulfate (SDS-PAGE, 12.5%). The proteins were
electroblotted onto PVDF membranes (0.45 µm) with a
Bio-Rad semidry-transfer-apparatus (constant 1.36 mA
per cm2). To assess the transfer efficiency and locate the
size marker, the membranes were stained with PonceauS-red. After 2 h of blocking (PBS/1% NP-40, 5% milk
powder), the membranes were incubated overnight
in blocking buffer with rabbit polyclonal antiserum
recognizing Bim (catalog no. 559685, BD Bioscience,
directed against amino acids 22–40 and diluted 1:1000)
or Bimbam (rabbit polyclonal antibody produced by
Gramsch Laboratories, Schwabhausen, Germany, against
AFLLTPSPSTLYFFKKTVTSC, amino acids in the
C-terminal region of Bimbam, and diluted 1:500). The
Bim antibody recognizes the 5’ end of Bim and Bimbam
proteins, whereas the Bimbam antibody recognizes
the C-terminal region of Bimbam only, which is not
present in any Bim variant. Each blot was also probed
using polyclonal antibodies against α-tubulin (CP06,
Calbiochem) as a protein loading control. The membranes
were washed 2 times for 10 min in PBS plus 1% NP-40
and then incubated with the antimouse or antirabbit
horseradish-peroxidase-conjugated secondary antibody
for 45 min at room temperature. After another washing
step (2 × 10 min), immune complexes were visualized
using an enhanced chemiluminescence reagent, ECL Plus
(Amersham Pharmacia Biotech), and exposure to AGFA
Curix X-ray films.
2.5. RNA preparation
For total RNA isolation, pellets of 5 × 106 cells were
lysed with 1 mL of TRI Reagent. After 10 min at room
temperature, 200 µL of chloroform was added, and the
mixture was vortexed and then centrifuged (17,000 ×
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Figure 1. Schematic representation of the Bim and Bam/Bimbam genes and their transcripts. The top panel shows the Bcl2L11
locus on chromosome 2 with the known Bim exons (i.e. 1–11) with green (coded) and black (noncoded) boxes. Below it the
chromosomal region encompassing exon 8 to exon 11 is enlarged to show the putative Bam gene derived from a cDNA clone
identified in a human myeloma. The predicted Bimbam mRNA has the 5’ region of Bim up to the BH3- domain (exon 8) and 3’
region of Bam. Moreover, the figure shows that both Bim and Bimbam transcripts are identical up to exon 8 but different in the
C-terminal region (not to scale).

g, 10 min, 4 °C). The RNA from the aqueous phase was
precipitated with 1.2 volumes of isopropanol for 10
minutes at –20 °C. The RNA was pelleted, washed in 70%
ethanol in DEPC-water, and finally resuspended in 30–40
µL of nuclease-free water (depending upon the size of the
RNA pellet).
2.6. Real-time SYBR Green RT-PCR
Our real time SYBR Green RT-PCR method using the
SYBR green qPCR kit (perfecTaTM SYBR Green SuperMix,
ROX) has been published (Mansha et al., 2012). Briefly, the
PCR master mix was made using 10 ng of cDNA, 100 nM
of Bimbam forward and reverse primers (both primers
were designed in the Bam region of this transcript:
Fwd., 5’-GCTTTTCTGCTCACACCCTC- and Rev.,
5’-GGCAACAGTAATCATTTCCAGA-), and 1X SYBR
Green SuperMix ROX in the final concentration with a
reaction volume of 25 µl. PCR mixes for Bim and Bimbam
and TBP (TATA-box binding protein) were discharged in
a 96-well plate, which was subsequently loaded in an IQ5
multicolor real-time PCR machine (Bio-Rad) and run with
a 2-step PCR thermoprotocol. Primary real-time PCR data
analysis was accomplished with SDS software version 2.2.1,
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and further analysis was done in programming language
R. Data from 3 technically replicated measurements were
averaged and normalized to the internal control (TBP). M
values, which are log2 fold change values, were calculated
for 3 biological triplicates by comparing normalized realtime PCR data from GC-treated samples against data
from the corresponding control samples. M values were
averaged for the 3 biological replicates.
3. Results
3.1 Detection of Bimbam transcripts in ALL cells
The existence of Bimbam transcript was analyzed by
RT-PCRs on mRNA from CEM-C7H2 cells treated
with dexamethasone for 24 h using Bimbam-specific
primers
5’-GGTAGACAATTGCAGCCTGC-3’
and
5’-AATTCCTTTGCTGCCTCC-3’, respectively. The
resulting 3 Bimbam RT-PCR products (of molecular weight
677, 497, and 407 bp) were TA-cloned and sequenced. The
products corresponded in sequence to transcripts derived
from the 3 major Bim splice variants (BimEL, BimL, and
BimS) in their 5’ region and from Bam in their 3’ region
(Figure 2). Thus, these RT-PCR data strongly suggested
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1018 bp
BimEL -Bam
506 bp

BimL -Bam
BimS -Bam

C7H2 - 24h dex

Figure 2. RT-PCR for Bimbam mRNA detection. CEM-C7H2
T-ALL cells were cultured for 24 h in the presence of 10–7 M
dexamethasone or 0.1% ethanol as the vehicle control and
subjected to RT-PCR with Bimbam specific primers. The first
row indicates the marker DNA while the second row shows the 3
splice variants of Bimbam.

that Bimbam transcripts exist in the investigated ALL cell
line. Similar to Bim, Bimbam appears to exist in 3 varieties
corresponding to 3 splice variants like those described for
Bim, namely BimEL-bam, BimL-bam, and BimS-bam.
3.2. Expression and regulation of Bim and Bimbam in
different biological systems
The basal expression and GC regulation of Bimbam in
relation to its relative Bim was examined in different
biological systems to understand the enigma of GCinduced cell death. The Affymetrix-based expression
profiling data from ALL patients revealed that Bimbam
was regulated by 3/5 T-ALL and 8/12 pre-B-ALL patients
as compared to Bim which was regulated by 2/5 T-ALL and
12/12 pre-B-ALL patients. A minute number of patients
regulated neither Bim nor Bimbam [Table; previously
reported for Bam as well (Mansha et al., 2011)].

3.3. Expression and regulation of Bim and Bimbam in
various in vitro leukemia models
To further extend our analysis regarding expression/
regulation of Bim and Bimbam in defined and experimentally
manageable systems, we exploited real time RT-PCR to
study various in vitro leukemia models (Figure 3).
Relative Bim expression levels in the absence of GC
among these cell lines were not dramatically different,
ranging from mean delta CT values of ~0.8 to 2.0. Thus, Bim
expression levels were between 1.7- and 4-fold lower than
those of the housekeeping gene TBP (Figure 3). We could
not see any noticeable link between GC-sensitivity (C7H2,
NALM6, and RS4;11 are GC-sensitive) or T/B-lineage
(C7H2 and MOLT4 are T-lineage cells; all others derive
from the B-lineage). Bimbam level in MOLT4 was similar
to those of the combined Bim transcripts. In the other cell
lines, they were ~1- to 2-fold lower than in Bim except for
C7H2, which was expressed ~4-fold less in Bimbam than
Bim. Concerning regulation by GC (Figure 4), induction
of Bimbam resembled that of Bim. GC-sensitive cells (e.g.,
C7H2, RS4;11) showed, in general, more pronounced GC
induction. The expression and regulation data of C7H2
have previously been reported (Mansha et al., 2011).
3.4. Analysis of Bimbam
3.4.1. Bimbam is a killer protein like Bim
To define the role of Bimbam in an ALL model with
conditional expression, CCRF-CEM-C7H2-2C8 cells were
transduced with a lentiviral construct containing human
BimELbam cDNA downstream of a tetracycline-responsive
promoter. Two stable cell lines, C7H2-2C8-Bimbam#2
(BB2) and Bimbam#14 (BB14), were generated. As little
as 6.25 ng/mL doxycycline led to a detectable induction of
Bimbam on mRNA level as well as on protein level (Figure 5).
3.4.2. The role of Bimbam in GC-induced cell death
To investigate a potential role of recombinant Bimbam
in cell death induction in ALL cells, the 2 characterized

Table. Expression profiling data for Bim and Bimbam in various lymphoid
systems. Data for Bim and Bimbam regulation were derived from 5 T-ALL
and 22 pre-B-ALL patients by Affymetrix-based whole genome expression
profiling. In the column for “regulated cases”, the number of individuals with
more than 2-fold regulation (M values of >1) is indicated. Mean regulations
were determined from the 6–8 h and 24 h M values for the individuals. The data
were previously reported for Bam (Mansha et al., 2011).
Regulated cases

Mean regulation

Bim

Bimbam

Bim

Bimbam

T-ALL (n = 5)

2

3

1.9 ± 1.1

2.2 ± 1.2

Precursor B-ALL (n = 22)

12

8

1.6 ± 0.5

1.9 ± 0.8

Biological system
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12.00
Bim

3.5

Bimbam

Mean fold change

4
Mean delta Ct

Regulation of Bim and Bimbam

Expression of Bim and Bimbam

4.5

3
2.5
2
1.5
1

C7H2

MOLT-4

NALM-6

RS4;11

AT-1

Figure 3. Bim and Bimbam expression in different leukemia
models. The indicated cell lines were cultured for 24 h in the
presence of 10–7 M dexamethasone or 0.1% ethanol as the vehicle
control and analyzed for Bim, Bimbam, and TBP (as internal
control) mRNA expression using quantitative real-time RTPCR. For each biological replicate of the 24 h dexamethasonetreated samples and vehicle controls, the CT value for TBP
was subtracted from the corresponding Bim or Bimbam value;
subsequently, mean and standard deviations were calculated.
Expression of these transcripts relative to TBP is shown. Note
that high levels in the figure mean low expression values.

subclones were cultured in the presence of increasing
doxycycline concentrations starting from 3.21 ng/mL up
to 200 ng/mL for 6 h, 12 h, and 24 h. Cells (3–5 × 105)
were harvested and stained with PI following the Nicoletti
protocol for apoptosis detection. As shown, Bimbam
induced little apoptosis after 6 h, but the rate of apoptosis
increased by a great magnitude (50%–60%) after 12 h
and even more after 24 h of doxycycline treatment. Thus,
transgenic Bimbam induced considerable apoptosis on its
own and might therefore contribute to the antileukemic
effects of GC in CEM-C7H2 cells and, by extension, in
other ALL cells as well (Figure 6).
3.4.3. Killing potency of Bimbam as compared to Bim
To determine the relative potency of Bimbam to Bim
in provoking cell death, C7H2-2C8-Bimbam#2 (with
conditional Bimbam expression) and a similar CEMC7H2-2C8 subclone with conditional expression of Bim
(Bim EL#17; Ploner, 2008) were treated with different
doxycycline concentrations for 24 h. After 6 h, samples
were examined for protein levels, and after 24 h, the cells
were subjected to apoptosis determination using flow
cytometric analysis of PI-stained nuclei. It was noted
that both Bim and Bimbam induced similar degrees
of apoptosis under similar amounts of doxycycline
treatment. Furthermore, to assess whether equal amounts
of doxycycline induced about equal amounts of transgenic
Bimbam and Bim, we analyzed protein expression levels
in the 6 h doxycycline-treated lysates from the above
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Bim
Bimbam

8.00
6.00
4.00
2.00
0.00

0.5
0

10.00

Figure 4. GC regulation of Bim and Bimbam in different
leukemia models. The indicated cell lines were cultured for 24 h
in the presence of 10–7 M or 0.1% ethanol as the vehicle control
and analyzed for Bim, Bimbam, and TBP (as internal control)
mRNA expression using quantitative real-time RT-PCR. For each
biological replicate of the 24 h dexamethasone-treated samples
and vehicle controls, the CT value for TBP was subtracted from
the corresponding Bim or Bimbam value; subsequently, mean
and standard deviations were calculated. Expression of these
transcripts relative to TBP is shown.

experiment using western blot analysis with the α-Bim
antibody. These analyses suggested that equal amounts of
doxycycline induced about equal amounts of Bimbam and
Bim proteins. Thus, Bimbam appears to be as potent as its
relative Bim in apoptosis induction (Figure 7).
3.4.4. Subcellular localization of Bimbam
The C-terminus of Bimbam is markedly different from that
of Bim in its amino acid sequence. To investigate whether
the unique C-terminus of Bimbam can alone confer
mitochondrial localization, we produced 2 constructs
expressing the C-termini of either Bim or Bimbam (using
the primers 5’-TTTTTGAATAATTACCAAGCAGCC5’-AATGCATTCTCCACACCAGfor
Bim
C-termini
and
5’-ATGATGTTTTCTTTACCCGC5’-CTAGGCAACAGTAATCATTTCfor
Bimbam
C-termini), each fused to the C-terminus of a YFP reporter
protein, and transiently transfected them into HEK-293T
cells. The laser scanning microscopy results revealed that
the Bim C-terminus conferred mitochondrial localization
to the YFP reporter protein as expected. The corresponding
Bimbam C-term-YFP, in contrast, was partly localized to
mitochondria and to other intracytoplasmic membranes
as well, suggesting that the Bimbam C-terminus does not
target mitochondria exclusively (Figure 8).
In the second set of experiments, full-length BimEL and
BimEL-bam were fused to the C-terminal region of the YFP
reporter protein to understand the subcellular localization
of Bimbam. It was seen that YFP-Bim exclusively localized
to mitochondria, again supporting the notion that the
C-terminus of Bim confers mitochondrial localization.

MANSHA et al. / Turk J Biol

(A)

(B)

(C)

Figure 5. Characterization of T-ALL cell lines with conditional Bimbam expression. C7H2-2C8-Bimbam#2 (BB2) and
C7H2-2C8-Bimbam#14 (BB14) cells were cultured in the presence of increasing concentrations of doxycycline (Dox)
and analyzed for Bimbam (and TBP as internal control) mRNA expression using quantitative real-time RT-PCR (A) or
immunoblotting with antibodies against Bim (B) or Bimbam (C) and α-tubulin as the loading control. The real-time RTPCR data are expressed as mean M values (log2 fold change) normalized to TBP. A dose-response curve for mRNA and
protein is shown for increasing dox concentrations.

YFP-Bimbam, in contrast, localized to mitochondria and
also to other endomembranes in the cytoplasm (Figure 8).
4. Discussion
Bimbam, an alternative Bim variant from BCL2L11,
appears potentially involved in the antileukemic effect of
GC. The experiments with specific SYBR Green RT-PCRs
suggested that Bimbam expression was somewhat lower
than that of Bim, but its regulation by GC was very similar
to that of Bim. However, in some children with ALL,
Bimbam appeared to be equally or even more strongly
regulated than Bim.
The quantification of BCL2L11 transcripts was
performed in a number of leukemia cell lines using SYBR
Green real-time RT-PCR. The data showed that Bim
expression was somewhat (~2-fold) higher than that of
Bimbam, and regulation by GC was about the same for Bim
and Bimbam transcripts.

The potential role of Bimbam in GC-induced apoptosis
was worked out with 2 stable cell lines, with conditional
overexpression of Bimbam. These data revealed that
transgenic Bimbam is a strong inducer of apoptosis like
its relative Bim. Comparative analyses between the killing
potencies of Bimbam and Bim revealed that both proteins
are about equally potent in inducing apoptosis.
Bimbam differs dramatically from its relative Bim due
to its unique C-terminal region. The C-terminus of Bim
(which is present in all major splice variants) contains a
potential membrane insertion sequence, which is targeted
to mitochondria through its hydrophobic C-terminal
domain (O’Connor et al., 1998). Moreover, it was proposed
that mitochondrial translocation of Bim, and not so much
its interaction with antiapoptotic BCL2 proteins, was the
key event in apoptosis induction (Weber et al., 2007). If
so, Bimbam, with a killing potency approximately equal
to that of Bim but a markedly different C-terminus, might
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Figure 6. Functional analysis of Bimbam. C7H2-2C8-BimELbam#2 and #14 clones
(expressing Bimbam in a doxycycline-dependent manner) were cultured in the
absence or presence of the indicated amounts of doxycycline for the indicated time
and subjected to apoptosis determination using flow cytometric analysis of PIstained nuclei. Since both cell lines gave very similar results, the data were combined.
Shown are mean percentages ± SD of nuclei in the sub-G1 window (“apoptosis”)
derived from biological triplicates.

(A)

(B)

Figure 7. Potency of Bimbam in comparison to Bim. C7H2-2C8-BimELbam#2 and C7H2-2C8-BimEL#17 (expressing Bimbam and
Bim in a doxycycline-dependent manner, respectively) were cultured in the absence or presence of 6.25 ng/mL, 12.5 ng/mL, or 25 ng/
mL of doxycycline (Dox) and subjected to apoptosis determination using flow cytometric analysis of PI-stained nuclei. Shown are mean
percentages ± SD of cells in sub-G1 (“apoptosis”) derived from biological triplicates of the 2 cell lines (A). Subsequently, the lysates were
subjected to western blot analysis using α-Bim antibody (detecting both Bim and Bimbam) and α-tubulin as the loading control (B).
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(A)

(B)

Figure 8. Subcellular localization of Bimbam. HEK293T cells were transiently
transfected for 24 h with recombinant YFP-Bimbam-C-term and YFP-Bim-C-term
constructs. The mitochondria were identified with Mitotracker staining. The merge part
of the figure shows that the YFP-Bim C-terminus localizes to mitochondria exclusively,
whereas the Bimbam C-terminus partly localizes to mitochondria (A). In the lower
panel full-length YFP-BimEL and YFP-BimEL-bam constructs were transfected and
the mitochondria were detected by COXVI antibody staining. The detailed part of the
figure shows that Bim exclusively localizes to mitochondria, whereas Bimbam localizes
to mitochondria but also to other cytoplasmic membranes (B).

induce cell death by a different mechanism. Contrary to
Bim, whose C-terminus exclusively targets mitochondria,
Bimbam’s C-terminus partly localized to mitochondria.
Similar results were observed when full-length YFPBimbam and YFP-Bim fusion proteins were studied.
However, we made the strong observation that Bimbam
also localized to additional cytoplasmic structures
(presumably the endoplasmic reticulum, ER). Our
findings question some reports suggesting that Bim targets

the ER as well (Morishima et al., 2004; Puthalakath et al.,
2007). As a possible explanation, strong overexpression
of transgenic Bim might exhaust the above described
selective localization pattern and lead to nonphysiological
targeting of the ER. In the case of detection of endogenous
Bim at the ER, it needs to be considered that commonly
used anti-Bim antibodies do not distinguish between
Bim and Bimbam, and hence it is unclear whether Bim or
Bimbam was detected at the ER.
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Recombinant Bimbam appears to be a promising
apoptotic protein, but we could not get conclusive
evidence regarding its endogenous existence on account
of the following: the presence of a splice event in the 3’
untranslational region of Bimbam generates an mRNA
that may be subject to nonsense-mediated mRNA decay,
making its efficient translation unlikely. The Bimbam
antibody is not so efficient for detecting endogenous
Bimbam protein or its expression is very low, at least in the
cell lines tested and with the detection systems used.
In conclusion, Bimbam is a novel GC-regulated
transcript from the BCL2L11 locus that appears to

contribute to GC-induced leukemia apoptosis, but we
could not collect sufficient clues regarding its endogenous
existence. In addition, it may be responsible for some of the
effects previously ascribed to the known Bim transcripts.
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